children
bronchiol
often
consid
homogen
group
howev
multicent
prospect
studi
young
children
hospit
bronchiol
found
children
respiratori
syncyti
viru
detect
differ
rhinoviru
detect
latter
patient
resembl
older
children
asthma
includ
frequent
treatment
corticosteroid
bronchiol
lead
caus
hospit
us
infant
caus
divers
group
virus
respiratori
syncyti
viru
rsv
common
viru
associ
sever
bronchiol
ie
bronchiol
requir
hospit
rhinoviru
second
common
american
academi
pediatr
bronchiol
clinic
practic
guidelin
recommend
clinician
test
children
bronchiol
virus
identifi
viral
etiolog
chang
child
manag
word
guidelin
suggest
bronchiol
treat
clinician
homogen
condit
despit
differ
viral
etiolog
emerg
evid
suggest
bronchiol
actual
heterogen
condit
differ
shortterm
longterm
outcom
base
small
studi
n
children
rhinovirusassoci
bronchiol
differ
demograph
like
prior
histori
wheez
often
treat
corticosteroid
acut
set
compar
young
children
infect
virus
moreov
children
hospit
rhinovirusassoci
bronchiol
shown
two
separ
popul
shorter
length
stay
children
rsv
bronchiol
addit
shortterm
differ
earli
childhood
rhinovirusassoci
wheez
ill
bronchiol
associ
increas
risk
schoolag
asthma
compar
rsvinduc
wheez
ill
taken
togeth
find
suggest
bronchiol
homogen
condit
recent
complet
prospect
multicent
multiyear
studi
children
hospit
bronchiol
secondari
analysi
hypothes
children
hospit
rhinovirusassoci
bronchiol
would
like
counterpart
rsv
infect
asthmalik
characterist
ie
prior
wheez
atop
characterist
frequent
treatment
corticosteroid
secondari
analysi
th
multicent
airway
research
collabor
prospect
observ
studi
children
hospit
bronchiol
studi
design
set
particip
method
data
collect
describ
previous
briefli
site
team
hospit
across
us
state
enrol
children
age
year
attend
physician
diagnosi
bronchiol
consecut
year
winter
season
use
standard
protocol
medic
decis
includ
test
virus
discret
treat
clinician
studi
period
site
routin
test
rhinoviru
institut
review
board
particip
hospit
approv
studi
investig
conduct
structur
interview
assess
patient
demograph
characterist
medic
histori
detail
acut
ill
preadmiss
daili
hospit
clinic
data
obtain
chart
review
nasopharyng
aspir
npa
collect
use
standard
protocol
polymeras
chain
reaction
pcr
assay
use
singleplex
duplex
twostep
real
time
pcr
rsv
type
b
rhinoviru
parainfluenza
viru
type
influenza
viru
type
b
novel
human
metapneumoviru
coronavirus
enteroviru
adenoviru
test
conduct
describ
previous
focus
analysi
rsv
rhinoviru
two
common
virus
caus
sever
bronchiol
creat
nonoverlap
categori
rsv
rsvrhinoviru
coinfect
rhinoviru
rsv
rhinoviru
categori
includ
viral
coinfect
except
rsvrhinoviru
sensit
analys
assess
differ
viru
combin
stratifi
age
month
month
month
restrict
analysi
children
firsttim
wheez
data
analyz
use
chisquar
test
unadjust
analys
multivari
logist
regress
adjust
analys
multivari
analysi
examin
associ
viru
detect
receiv
corticosteroid
emerg
depart
ed
hospit
composit
outcom
includ
children
prescrib
corticosteroid
either
two
differ
care
team
ie
ed
inpati
data
present
proport
median
interquartil
rang
iqr
odd
ratio
or
confid
interv
ci
analys
perform
use
stata
stata
corp
colleg
station
tx
studi
period
enrol
children
hospit
bronchiol
median
age
month
iqr
month
male
black
among
children
rsv
rsv
rhinoviru
coinfect
rhinoviru
children
nonrsv
nonrhinoviru
infect
identifi
viral
infect
exclud
current
analysi
shown
tabl
children
posit
rhinoviru
like
older
histori
wheez
histori
eczema
differ
observ
respect
parent
histori
asthma
children
rhinoviru
also
like
receiv
system
corticosteroid
ed
current
hospit
multivari
model
control
age
sex
race
histori
wheez
histori
eczema
treatment
inhal
corticosteroid
past
week
cluster
site
children
rhinoviru
like
prescrib
system
corticosteroid
ed
hospit
children
rsv
ci
p
children
rsvrhinoviru
coinfect
higher
odd
prescrib
corticosteroid
children
rsv
ci
result
materi
chang
sensit
analys
compar
differ
combin
virus
includ
rsvonli
rhinovirusonli
stratifi
age
month
month
month
restrict
analyt
cohort
children
first
time
wheez
tabl
ii
avail
wwwjpedscom
larg
multicent
multiyear
studi
children
hospit
bronchiol
found
children
rhinovirusassoci
bronchiol
resembl
older
children
asthma
compar
children
rsvassoci
bronchiol
children
rhinovirusassoci
bronchiol
like
older
priorhistori
wheez
eczema
furthermor
multivari
model
children
hospit
rhinovirusassoci
bronchiol
like
treat
system
corticosteroid
even
control
age
sex
race
histori
wheez
eczema
inhal
corticosteroid
use
differenti
treatment
children
rhinovirusassoci
bronchiol
clinician
academ
medic
center
across
us
implicit
acknowledg
treat
clinician
consid
bronchiol
heterogen
respiratori
ill
next
step
determin
identifi
subgroup
children
bronchiol
eg
rhinoviru
posit
histori
wheez
may
respond
differ
medic
eg
albuterol
system
corticosteroid
may
need
closer
longterm
followup
given
potenti
higher
risk
asthma
medic
test
random
control
trial
children
hospit
bronchiol
one
use
treat
children
asthma
exacerb
eg
bronchodil
agent
system
corticosteroid
date
mani
largescal
bronchiol
medic
trial
requir
children
age
month
histori
wheez
base
present
data
inclus
criteria
may
creat
fairli
homogen
studi
popul
children
rsv
bronchiol
although
rsv
common
viral
etiolog
sever
bronchiol
result
well
conduct
studi
remain
valid
present
data
combin
report
suggest
largescal
studi
probabl
repeat
children
rhinovirusassoci
bronchiol
chang
practic
subgroup
would
affect
shortterm
outcom
estim
us
children
age
year
hospit
annual
rhinovirusassoci
bronchiol
mani
worldwid
repeat
treatment
trial
also
may
prove
import
longterm
outcom
infant
sever
bronchiol
recogn
childhood
asthma
children
rhinovirusassoci
bronchiol
may
particularli
high
risk
unfortun
instrument
yet
reliabl
predict
children
bronchiol
develop
asthma
also
mean
accur
conduct
prevent
trial
inde
unlik
primari
asthma
prevent
effort
success
treat
children
bronchiol
homogen
group
without
identifi
children
ideal
infant
highest
risk
shortand
longterm
outcom
one
help
step
would
develop
better
outcomeori
case
definit
children
age
year
come
medic
attent
nonbacteri
lower
respiratori
infect
current
clinician
use
variabl
diagnost
label
eg
bronchiol
reactiv
airway
diseas
cough
asthma
children
lower
respiratori
infect
provid
better
guidanc
case
definit
outcom
clinician
continu
use
asthma
exacerb
medic
eg
albuterol
system
corticosteroid
children
age
year
lower
respiratori
infect
base
intuit
rather
scientif
data
present
studi
potenti
limit
first
studi
popul
compris
children
hospit
academ
medic
center
therefor
result
necessarili
generaliz
clinic
set
second
neg
rapid
rsv
test
may
influenc
clinician
decis
begin
corticosteroid
although
nation
guidelin
support
strategi
third
rhinoviru
detect
asymptomat
children
frequent
consid
bystand
viru
patient
rhinoviru
detect
wheez
could
manifest
extant
asthma
suggest
futur
research
focu
identifi
children
age
year
bronchiol
may
benefit
shortterm
possibl
longterm
medic
current
use
treat
older
children
asthma
